The quaternary lidocaine derivative, QX-314, exerts biphasic effects on transient receptor potential vanilloid subtype 1 channels in vitro

Anesthesiology

Volumn 114, Issue 6, 2011, Pages 1425-1434

  Rivera Acevedo, Ricardo E ^a   Pless, Stephan A ^a   Ahern, Christopher A ^a   Schwarz, Stephan K W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CAPSAZEPINE; LIDOCAINE ETHOBROMIDE; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 4;

ANIMAL CELL; CONFERENCE PAPER; CONFOCAL MICROSCOPY; IC 50; NONHUMAN; OOCYTE; PRIORITY JOURNAL; VOLTAGE CLAMP; XENOPUS LAEVIS;

EID: 85027936054     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318216ea0c     Document Type: Conference Paper

References (65)

1. Gomtsyan A, Bayburt EK, Schmidt RG, Zheng GZ, Perner RJ, Didomenico S, Koenig JR, Turner S, Jinkerson T, Drizin I, Hannick SM, Macri BS, McDonald HA, Honore P, Wismer CT, Marsh KC, Wetter J, Stewart KD, Oie T, Jarvis MF, Surowy CS, Faltynek CR, Lee CH: Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: Structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties. J Med Chem 2005; 48:744-52. (Pubitemid 40209096)
2. Veronesi B, Oortgiesen M: The TRPV1 receptor: Target of toxicants and therapeutics. Toxicol Sci 2006; 89:1-3. (Pubitemid 43013750)
3. Roberts LA, Connor M: TRPV1 antagonists as a potential treatment for hyperalgesia. Recent Pat CNS Drug Discov 2006; 1:65-76.
4. Wang HL, Katon J, Balan C, Bannon AW, Bernard C, Doherty EM, Dominguez C, Gavva NR, Gore V, Ma V, Nishimura N, Surapaneni S, Tang P, Tamir R, Thiel O, Treanor JJ, Norman MH: Novel vanilloid receptor-1 antagonists: 3. The identification of a second-generation clinical candidate with improved physicochemical and pharmacokinetic properties. J Med Chem 2007; 50:3528-39.
5. Patapoutian A, Tate S, Woolf CJ: Transient receptor potential channels: Targeting pain at the source. Nat Rev Drug Discov 2009; 8:55-68.
6. Premkumar LS: Targeting TRPV1 as an alternative approach to narcotic analgesics to treat chronic pain conditions. AAPS J 2010; 12:361-70.
7. Lim TKY, MacLeod BA, Ries CR, Schwarz SKW: The quaternary lidocaine derivative, QX-314, produces long-lasting local anesthesia in animal models in vivo. ANESTHESIOLOGY 2007; 107:305-11. (Pubitemid 47196495)
8. Binshtok AM, Bean BP, Woolf CJ: Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers. Nature 2007; 449:607-10. (Pubitemid 47525153)
9. Ries CR, Pillai R, Chung CCW, Wang JTC, MacLeod BA, Schwarz SKW: QX-314 produces long-lasting local anesthesia modulated by transient receptor potential vanilloid receptors in mice. ANESTHESIOLOGY 2009; 111:122-6.
10. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D: The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 1997; 389:816-24. (Pubitemid 27462969)
11. Holzer P: Local effector functions of capsaicin-sensitive sensory nerve endings: Involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988; 24:739-68.
12. Szallasi A, Cortright DN, Blum CA, Eid SR: The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov 2007; 6:357-72. (Pubitemid 46705200)
13. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, Julius D: The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998; 21:531-43. (Pubitemid 28475505)
14. Jordt SE, Tominaga M, Julius D: Acid potentiation of the capsaicin receptor determined by a key extracellular site. Proc Natl Acad Sci USA 2000; 97:8134-9. (Pubitemid 30460785)
15. Dhaka A, Uzzell V, Dubin AE, Mathur J, Petrus M, Bandell M, Patapoutian A: TRPV1 is activated by both acidic and basic pH. J Neurosci 2009; 29:153-8.
16. Cesare P, Dekker LV, Sardini A, Parker PJ, McNaughton PA: Specific involvement of PKC- in sensitization of the neuronal response to painful heat. Neuron 1999; 23:617-24. (Pubitemid 29359931)
17. Chuang HH, Prescott ED, Kong H, Shields S, Jordt SE, Basbaum AI, Chao MV, Julius D: Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 2001; 411:957-62. (Pubitemid 32601493)
18. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sørgård M, Di Marzo V, Julius D, Högestätt ED: Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999; 400:452-7. (Pubitemid 29361798)
19. Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, Tognetto M, Petros TJ, Krey JF, Chu CJ, Miller JD, Davies SN, Geppetti P, Walker JM, Di Marzo V: An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 2002; 99:8400-5. (Pubitemid 34651064)
20. Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, Jung J, Cho S, Min KH, Suh YG, Kim D, Oh U: Direct activation of capsaicin receptors by products of lipoxygenases: Endogenous capsaicin-like substances. Proc Natl Acad Sci USA 2000; 97: 6155-60.
21. Shin J, Cho H, Hwang SW, Jung J, Shin CY, Lee SY, Kim SH, Lee MG, Choi YH, Kim J, Haber NA, Reichling DB, Khasar S, Levine JD, Oh U: Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci USA 2002; 99:10150-5. (Pubitemid 34831187)
22. Moriyama T, Higashi T, Togashi K, Iida T, Segi E, Sugimoto Y, Tominaga T, Narumiya S, Tominaga M: Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol Pain 2005; 1:3.
23. Tominaga M, Wada M, Masu M: Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possi-ble mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci USA 2001; 98:6951-6. (Pubitemid 32538323)
24. Cuypers E, Yanagihara A, Karlsson E, Tytgat J: Jellyfish and other cnidarian envenomations cause pain by affecting TRPV1 channels. FEBS Lett 2006; 580:5728-32.
25. Siemens J, Zhou S, Piskorowski R, Nikai T, Lumpkin EA, Basbaum AI, King D, Julius D: Spider toxins activate the capsaicin receptor to produce inflammatory pain. Nature 2006; 444:208-12. (Pubitemid 44722061)
26. Cornett PM, Matta JA, Ahern GP: General anesthetics sensitize the capsaicin receptor transient receptor potential V1. Mol Pharmacol 2008; 74:1261-8.
27. Fischer MJ, Leffler A, Niedermirtl F, Kistner K, Eberhardt M, Reeh PW, Nau C: The general anesthetic propofol excites nociceptors by activating TRPV1 and TRPA1 rather than GABAA receptors. J Biol Chem 2010; 285:34781-92.
28. Leffler A, Fischer MJ, Rehner D, Kienel S, Kistner K, Sauer SK, Gavva NR, Reeh PW, Nau C: The vanilloid receptor TRPV1 is activated and sensitized by local anesthetics in rodent sensory neurons. J Clin Invest 2008; 118:763-76. (Pubitemid 351206564)
29. Schwarz SKW, Cheung HMC, Ries CR, Lee SM, Wang JTC, MacLeod BA: Lumbar intrathecal administration of the quaternary lidocaine derivative, QX-314, produces irritation and death in mice. ANESTHESIOLOGY 2010; 113:438-44.
30. Jordt SE, Julius D: Molecular basis for species-specific sensitivity to "hot" chili peppers. Cell 2002; 108:421-30. (Pubitemid 34178405)
31. Yifrach O: Hill coefficient for estimating the magnitude of cooperativity in gating transitions of voltage-dependent ion channels. Biophys J 2004; 87:822-30. (Pubitemid 39095065)
32. Mohapatra DP, Wang SY, Wang GK, Nau C: A tyrosine residue in TM6 of the vanilloid receptor TRPV1 involved in desensitization and calcium permeability of capsaicin-activated currents. Mol Cell Neurosci 2003; 23:314-24. (Pubitemid 36703165)
33. Mohapatra DP, Nau C: Desensitization of capsaicin-activated currents in the vanilloid receptor TRPV1 is decreased by the cyclic AMP-dependent protein kinase pathway. J Biol Chem 2003; 278:50080-90. (Pubitemid 37548845)
34. Ciura S, Bourque CW: Transient receptor potential vanilloid 1 is required for intrinsic osmoreception in organum vasculosum lamina terminalis neurons and for normal thirst responses to systemic hyperosmolality. J Neurosci 2006; 26: 9069-75.
35. Gavva NR, Klionsky L, Qu Y, Shi L, Tamir R, Edenson S, Zhang TJ, Viswanadhan VN, Toth A, Pearce LV, Vanderah TW, Porreca F, Blumberg PM, Lile J, Sun Y, Wild K, Louis JC, Treanor JJ: Molecular determinants of vanilloid sensitivity in TRPV1. J Biol Chem 2004; 279:20283-95. (Pubitemid 38623474)
36. Bevan S, Hothi S, Hughes G, James IF, Rang HP, Shah K, Walpole CS, Yeats JC: Capsazepine: A competitive antagonist of the sensory neurone excitant capsaicin. Br J Pharmacol 1992; 107:544-52.
37. Walpole CS, Bevan S, Bovermann G, Boelsterli JJ, Breckenridge R, Davies JW, Hughes GA, James I, Oberer L, Winter J: The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin. J Med Chem 1994; 37:1942-54.
38. Garcia RL, Schilling WP: Differential expression of mammalian TRP homologues across tissues and cell lines. Biochem Biophys Res Commun 1997; 239:279-83. (Pubitemid 27480356)
39. Kunert-Keil C, Bisping F, Kruger J, Brinkmeier H: Tissuespecific expression of TRP channel genes in the mouse and its variation in three different mouse strains. BMC Genomics 2006; 7:159.
40. Güler AD, Lee H, Iida T, Shimizu I, Tominaga M, Caterina M: Heat-evoked activation of the ion channel, TRPV4. J Neurosci 2002; 22:6408-14.
41. Liedtke W, Choe Y, Martí-Renom MA, Bell AM, Denis CS, Sali A, Hudspeth AJ, Friedman JM, Heller S: Vanilloid receptorrelated osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 2000; 103:525-35.
42. Watanabe H, Vriens J, Suh SH, Benham CD, Droogmans G, Nilius B: Heat-evoked activation of TRPV4 channels in a HEK293 cell expression system and in native mouse aorta endothelial cells. J Biol Chem 2002; 277:47044-51. (Pubitemid 36159212)
43. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B: Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 2003; 424:434-8. (Pubitemid 36917492)
44. Strotmann R, Harteneck C, Nunnenmacher K, Schultz G, Plant TD: OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity. Nat Cell Biol 2000; 2:695-702.
45. Suzuki M, Mizuno A, Kodaira K, Imai M: Impaired pressure sensation in mice lacking TRPV4. J Biol Chem 2003; 278: 22664-8. (Pubitemid 36830325)
46. Thodeti CK, Matthews B, Ravi A, Mammoto A, Ghosh K, Bracha AL, Ingber DE: TRPV4 channels mediate cyclic straininduced endothelial cell reorientation through integrin-tointegrin signaling. Circ Res 2009; 104:1123-30.
47. Gao X, Wu L, O'Neil RG: Temperature-modulated diversity of TRPV4 channel gating: Activation by physical stresses and phorbol ester derivatives through protein kinase C-dependent and-independent pathways. J Biol Chem 2003; 278: 27129-37. (Pubitemid 36876868)
48. Thorneloe KS, Sulpizio AC, Lin Z, Figueroa DJ, Clouse AK, McCafferty GP, Chendrimada TP, Lashinger ES, Gordon E, Evans L, Misajet BA, Demarini DJ, Nation JH, Casillas LN, Marquis RW, Votta BJ, Sheardown SA, Xu X, Brooks DP, Laping NJ, Westfall TD: N-((1S)-1-{[4-((2S)-2-{[(2,4-Dichloro phenyl)sulfonyl]amino}-3- hydroxypropanoyl)-1-piperazinyl] carbonyl}-3-methylbutyl)-1-benzothiophene-2- carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I. J Pharmacol Exp Ther 2008; 326:432-42.
49. Arndt KA, Burton C, Noe JM: Minimizing the pain of local anesthesia. Plast Reconstr Surg 1983; 72:676-9. (Pubitemid 13023268)
50. de Jong RH, Cullen SC: Buffer-demand and pH of local anesthetic solutions containing epinephrine. ANESTHESIOLOGY 1963; 24:801-7.
51. Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, Julius D: Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000; 288:306-13. (Pubitemid 30226186)
52. Leffler A, Mönter B, Koltzenburg M: The role of the capsaicin receptor TRPV1 and acid-sensing ion channels (ASICS) in proton sensitivity of subpopulations of primary nociceptive neurons in rats and mice. Neuroscience 2006; 139:699-709.
53. Shin CY, Shin J, Kim BM, Wang MH, Jang JH, Surh YJ, Oh U: Essential role of mitochondrial permeability transition in vanilloid receptor 1-dependent cell death of sensory neurons. Mol Cell Neurosci 2003; 24:57-68. (Pubitemid 37194533)
54. Amantini C, Mosca M, Nabissi M, Lucciarini R, Caprodossi S, Arcella A, Giangaspero F, Santoni G: Capsaicin-induced apoptosis of glioma cells is mediated by TRPV1 vanilloid receptor and requires p38 MAPK activation. J Neurochem 2007; 102:977-90. (Pubitemid 47057292)
55. Thomas KC, Sabnis AS, Johansen ME, Lanza DL, Moos PJ, Yost GS, Reilly CA: Transient receptor potential vanilloid 1 agonists cause endoplasmic reticulum stress and cell death in human lung cells. J Pharmacol Exp Ther 2007; 321:830-8. (Pubitemid 46762717)
56. Friederich P, Schmitz TP: Lidocaine-induced cell death in a human model of neuronal apoptosis. Eur J Anaesthesiol 2002; 19:564-70. (Pubitemid 34855559)
57. Johnson ME, Uhl CB, Spittler KH, Wang H, Gores GJ: Mitochondrial injury and caspase activation by the local anesthetic lidocaine. ANESTHESIOLOGY 2004; 101:1184-94.
58. Seitz RJ, Lipfert P, Willrich A, Himmelmann F: Toxic effects of triethyldodecylammoniumbromide (TEA-C12) on myelin-ated nerve fibers and blood-nerve barrier in the mouse. Exp Brain Res 1989; 74:293-302. (Pubitemid 19043236)
59. Gerner P, Mujtaba M, Khan M, Sudoh Y, Vlassakov K, Anthony DC, Wang GK: N-phenylethyl amitriptyline in rat sciatic nerve blockade. ANESTHESIOLOGY 2002; 96:1435-42.
60. Gerner P, Luo SH, Zhuang ZY, Djalali AG, Zizza AM, Myers RR, Wang GK: Differential block of N-propyl derivatives of amitriptyline and doxepin for sciatic nerve block in rats. Reg Anesth Pain Med 2005; 30:344-50. (Pubitemid 40992861)
61. Sudoh Y, Cahoon EE, De Girolami U, Wang GK: Local anesthetic properties of a novel derivative, N-methyl doxepin, versus doxepin and bupivacaine. Anesth Analg 2004; 98: 672-6. (Pubitemid 38252656)
62. Wang GK, Quan C, Vladimirov M, Mok WM, Thalhammer JG: Quaternary ammonium derivative of lidocaine as a longacting local anesthetic. ANESTHESIOLOGY 1995; 83:1293-301.
63. Gerner P, Nakamura T, Quan CF, Anthony DC, Wang GK: Spinal tonicaine: Potency and differential blockade of sensory and motor functions. ANESTHESIOLOGY 2000; 92:1350-60.
64. Khan MA, Gerner P, Sudoh Y, Wang GK: Use of a charged lidocaine derivative, tonicaine, for prolonged infiltration anesthesia. Reg Anesth Pain Med 2002; 27:173-9. (Pubitemid 34258241)
65. Jara-Oseguera A, Llorente I, Rosenbaum T, Islas LD: Properties of the inner pore region of TRPV1 channels revealed by block with quaternary ammoniums. J Gen Physiol 2008; 132:547-62